Innate Pharma (IPHA) Balance Sheet

Innate Pharma's total assets for Q4 2025 were €62.69M, a decrease of -32.54% from the previous quarter. IPHA total liabilities were €84.39M for the fiscal quarter, a -3.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.